National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

therapeutic triiodothyronine
A therapeutic formulation of the primary physiologically active form of endogenous thyroid hormone. In vivo, triiodothyronine enters the nucleus and binds to nuclear thyroid hormone receptors that subsequently bind to thyroid response elements (TREs) located in target genes. Receptor binding by triiodothyronine in combination with recruited coactivators results in maximal transcriptional activation after binding to TREs; in general, binding of thyroid hormone receptor alone to TREs leads to repression of gene transcription. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Liothyronine
L-Triiodothyronine
Triiodothyronine
Abbreviation:Therapeutic T3



Previous:therapeutic hydrocortisone, therapeutic immune globulin, therapeutic melatonin, therapeutic progesterone, therapeutic testosterone
Next:therapeutic tumor infiltrating lymphocytes, TheraSphere, ThermoDox, thiabendazole, thiamine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov